# New coronavirus pneumonia diagnosis and treatment plan (trial version 7)

Since December 2019, a new coronavirus pneumonia epidemic has appeared in Wuhan, Hubei Province, China. With the spread of the epidemic, other cases in China and many countries outside the country have also found such cases. As an acute respiratory infectious disease, the disease has been included in the Class B infectious diseases stipulated in the Law of the People's Republic of China on the Prevention and Control of Infectious Diseases, and is managed as a Class A infectious disease. Through the adoption of a series of preventive control and medical treatment measures, the upward trend of the epidemic situation in China has been contained to a certain extent. The epidemic situation in most provinces has eased, but the number of outbreaks abroad is on the rise. With the deepening of the clinical manifestations, pathological understanding of the disease, and the accumulation of experience in diagnosis and treatment, in order to further strengthen the early diagnosis and early treatment of the disease, improve the cure rate, reduce the mortality rate, and avoid hospital infection as much as possible, and remind the attention of overseas input The case caused the spread and spread. We revised the "New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Version 6)" to form the "New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Version 7).

table of Contents
#### 1. [Etiology Features](./1.md)
#### 2. [Epidemiology Features](./2.md)
#### 3. [pathological changes](./3.md)
#### 4. [Clinical Features](./4.md)
#### 5. [Diagnostic Criteria](./5.md)
#### 6. [Clinical typing](./6.md)
#### 7. [Critical and Early Warning Indicators for Heavy and Critical Severity](./7.md)
#### 8. [Differential diagnosis](./8.md)
#### 9. [Case Discovery and Reporting](./9.md)
#### 10. [Treatment](./10.md)
#### 11. [discharge standards and precautions after discharge](./11.md)
#### 12. [Transfer Principle](./12.md)
#### 13. [Infection Prevention and Control in Medical Institutions](./13.md)
